[1]
C. Ngernsombat, U. Suriya, S. Udompaisarn, N. Panomchoeng, and T. Janvilisri, “Candesartan cilexetil as a repurposed therapeutic candidate for nasopharyngeal carcinoma: Integrated in vitro and in silico analyses”, EXCLI J., vol. 25, pp. 204–221, Jan. 2026.